DEXTROSE ORAL GEL

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, with CAGE code 1UNB0, for the procurement of 4.000 packages of DEXTROSE ORAL GEL, identified by NSN 6505014253168 and NDC codes 00574-0069-30 and 72847-0213-15, at a total contract value of $40.28. The award, issued on July 19, 2026, with a delivery date of July 20, 2026, is FOB Destination to the USNS IMPECCABLE at FPO AP 96668, with inspection and acceptance performed by the government upon arrival. The contractor is certified as a small business, small disadvantaged business, and women-owned small business, with compliance required through the System for Award Management. Shipment must utilize traceable methods and prohibit parcel post, with all packaging and documentation marked with both the base contract and delivery order numbers. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, under appropriation data BX: 97X4930 5CBX 001 2620 S33189, using a voucher-based invoicing system. No separate contract clauses, special requirements, or evaluation factors were detailed in the documentation, and while MIL-STD references are absent, standard DoD supply chain practices are implied. The contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena, and no Contracting Officer’s Representative is designated. The order is a single-line-item purchase under a broader indefinite delivery vehicle, reflecting simplified acquisition procedures typical for low-value commercial medical supplies.